Age‑related macular degeneration (AMD) is a progressive eye disease that affects the macula, the central part of the retina, leading to loss of central vision. At Claire Vision Eye Care, we prioritize early detection and customized treatment strategies, offering patients world‑class expert care.

Understanding AMD

AMD comes in two forms—dry (atrophic) and wet (neovascular). Initially, small deposits called drusen accumulate under the retina. While some hard drusen are common with aging, larger soft drusen signal early AMD. Without timely intervention, these can impair the retinal pigment epithelium and photoreceptor cells.

Recognizing Symptoms

Key symptoms include:

• Blurred or scotopic central vision

• Straight lines appearing wavy (metamorphopsia) or missing areas

• Difficulty reading, recognizing faces, or driving at night

These signs often emerge gradually during dry AMD, but can rapidly escalate in the wet form, where abnormal blood vessels leak beneath the retina.

Who Is At Risk?

Age is the foremost risk factor—people over 50 are more vulnerable. Other contributing factors include genetics, smoking, high blood pressure, high cholesterol, obesity, and diet. Lifestyle modification, including smoking cessation and dietary improvements, plays a crucial role in disease management.

Advanced Diagnostic Care

Claire Vision Eye Care in Wakad employs cutting‑edge diagnostics—fundus photography, optical coherence tomography (OCT), and Amsler grid testing—to detect early changes. These tests are essential for tailoring personalized treatment plans.

State‑of‑the‑Art Treatment Options

• Dry AMD: Management involves lifestyle optimization, dietary changes, and AREDS‑formulation antioxidant supplements. AREDS‑2 formula (containing lutein and zeaxanthin) has been shown to slow progression in early‑intermediate stages.
• Wet AMD: The cornerstone of treatment is intravitreal anti‑VEGF injections (e.g., ranibizumab, aflibercept, bevacizumab) to inhibit abnormal blood vessel growth and leakage Faricimab (Vabysmo), a newer dual‑action agent targeting VEGF and Ang‑2, has recently gained approval for neovascular AMD
• Emerging Therapies: Gene therapy and stem cell approaches are in clinical development, offering future hope for vision restoration

Why Choose Expert Care at Claire Vision

Our team of seasoned ophthalmologists delivers a holistic approach—from thorough diagnostics and personalized treatment plans to ongoing monitoring and lifestyle education. We ensure that AMD patients receive the most advanced available treatments, including the latest injections and experimental protocols when appropriate.

Patient Empowerment & Monitoring

Patients are educated on self‑monitoring tools, such as the Amsler grid, enabling early detection of visual changes. Regular follow‑ups and retinal imaging are integral to managing AMD progression.